CRISPR Therapeutics AG (CRSP) has 223 open-market insider trades by 25 insiders since 2016. Over the last six months insiders net sold $1.2M. The most active filer is Samarth Kulkarni, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Bradley J. Bolzon Ph.D. | Dir | — | 26 | $162.2M | 2021-07-19 |
| Simeon George | Dir | — | 2 | $103.9M | 2025-07-16 |
| Kurt Von Emster | Dir | — | 24 | $95.2M | 2018-12-18 |
| Rodger Novak | Pres | — | 40 | $72.8M | 2021-06-30 |
| Samarth Kulkarni | CEO | — | 41 | $56.8M | 2026-10-14 |
| Celgene Corp. /de/ | 10% Owner | — | 16 | $42.0M | 2018-11-21 |
| Thomas Woiwode | Dir | — | 10 | $35.8M | 2018-05-15 |
| Lawrence Otto Klein | COO | — | 5 | $25.9M | 2022-03-14 |
| Aktiengesellschaft Bayer | 10% Owner | — | 1 | $12.0M | 2018-01-05 |
| James R. Kasinger | CLOSecretary | — | 13 | $9.1M | 2026-10-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Samarth Kulkarni | CEO | Sell | $202K | 2026-10-14 |
| James R. Kasinger | CLO & Secretary | Sell | $51K | 2026-10-14 |
| Versant Venture Capital IV, L.P. | Director | Sell | $720K | 2026-10-14 |
| James R. Kasinger | CLO & Secretary | Sell | $119K | 2026-10-06 |
| James R. Kasinger | CLO & Secretary | Sell | $626K | 2026-09-22 |
| Versant Venture Capital IV, L.P. | Director | Sell | $781K |
Companies that share insiders with CRSP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-09-17 |
| Naimish Patel | — | Sell | $211K | 2026-05-29 |
| James R. Kasinger | CLO & Secretary | Sell | $149K | 2026-03-23 |
| Samarth Kulkarni | CEO | Sell | $469K | 2026-03-23 |
| Raju Prasad | CFO | Sell | $173K | 2026-03-23 |
| Raju Prasad | CFO | Sell | $476K | 2026-03-16 |
| Samarth Kulkarni | CEO | Sell | $499K | 2026-03-16 |
| Naimish Patel | — | Sell | $152K | 2026-03-16 |
| James R. Kasinger | CLO & Secretary | Sell | $166K | 2026-03-16 |
| James R. Kasinger | Secretary | Sell | $148K | 2026-03-11 |